Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Abeona Therapeutics (ABEO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Abeona Therapeutics 3333 LEE PARKWAY SUITE 600 DALLAS TX 75219 USA

P: 214-665-9495

Description:

Abeona Therapeutics, Inc. is engaged in developing and delivering gene therapy and plasma-based products for rare diseases. Abeona Therapeutics Inc., formerly known as PlasmaTech Biopharmaceuticals, Inc., is based in Dallas, United States.

Key Statistics

Overview:

Market Capitalization, $K 264,000
Shares Outstanding, K 49,162
Annual Sales, $ 3,000 K
Annual Net Income, $ -56,670 K
Last Quarter Sales, $ -2,130 K
Last Quarter Net Income, $ -20,090 K
60-Month Beta 2.13
% of Insider Shareholders 33.60%
% of Institutional Shareholders 63.61%
Float, K 32,644
% Float 66.40%

Growth:

1-Year Return -68.49%
3-Year Return 109.77%
5-Year Return -63.72%
5-Year Revenue Growth 47.06%
5-Year Earnings Growth 90.48%
5-Year Dividend Growth 0.00%

Per-Share Information:

Next Earnings Date 08/08/19
Earnings Per Share ttm -1.13
EPS Growth vs. Prev Qtr -8.33%
EPS Growth vs. Prev Year -116.67%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00
Most Recent Split 1-50 on 10/24/14

ABEO Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward -13.52
Price/Earnings to Growth N/A
Return-on-Equity (After Tax) -45.58
Return-on-Assets (Before Tax) -38.43
Profit Margin % -1,889.00
Net Margin % N/A
Debt/Equity 0.00
Price/Sales 84.78
Price/Cash Flow N/A
Price/Book 2.17
Book Value/Share 2.80
Interest Coverage -5,666.00
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar